Ginkgo Bioworks Holdings, Inc.DNANYSE
LOADING
|||
EBITDA Over Time
Trending higher, above historical average, strong compound growth.
Left:
||||
Earnings before interest, taxes, depreciation, and amortization
Latest
$-484.39M
↑ 46% above average
Average (5y)
$-897.88M
Historical baseline
Range
High:$-106.66M
Low:$-2.06B
CAGR
+35.3%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-484.39M | +41.0% |
| 2023 | $-821.29M | +60.1% |
| 2022 | $-2.06B | -14.0% |
| 2021 | $-1.81B | -1563.8% |
| 2020 | $-108.58M | -1.8% |
| 2019 | $-106.66M | - |